After extensive research and development, Neotonus has introduced NeoControl®, the first product to utilize patented ExMI™ technology. NeoControl was cleared by the U.S. Food and Drug Administration (FDA) in June of 1998 for the treatment of stress, urge and mixed incontinence in women. NeoControl is a complete pelvic floor therapy system consisting of two main components, the Control Unit and the Treatment Chair.

The Control Unit provides the operator interface, basic system control, system status, pulse generation and external communication via a modem.

The Treatment Chair houses the therapy head, which generates the magnetic fields and facilitates proper patient positioning. Compact and requiring only standard 110VAC power, the complete system fits easily into an office or clinic environment.

The NeoControl device has been very well accepted by physicians worldwide. Two sample testimonials from renowned U.S. doctors can be found here and here. To view video testimonials, visit our Press Room.